Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

COMMONWEALTH OF VIRGINIA STATE BOARD OF HEALTH

Subsidiary ofCOMMONWEALTH OF VIRGINIAUEI: WG23DWXFNL81CAGE: 4C963

COMMONWEALTH OF VIRGINIA STATE BOARD OF HEALTH is a federal contractor, registered under UEI WG23DWXFNL81 and CAGE code 4C963. It has been awarded $1,669,248,300 in federal contracts. Primary work spans Unknown NAICS and Other NAICS codes (3 codes, <0.5% each). Top awarding agencies include Department Of Health And Human Services and Other agencies (2 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

WG23DWXFNL81

CAGE Code

4C963

Entity Structure

U.S. Government Entity

Established

N/A

Business Classifications

U.S State Government

NAICS Codes

923120Administration of Public Health Programs(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

The Commonwealth of Virginia State Board of Health provides specialized biological specimen collection, processing, and distribution services for advanced neurobiological research, primarily supporting federal neuroscience initiatives. Their core capability centers on the ethical procurement, preser...

The Commonwealth of Virginia State Board of Health provides specialized biological specimen collection, processing, and distribution services for advanced neurobiological research, primarily supporting federal neuroscience initiatives. Their core capability centers on the ethical procurement, preservation, and logistical coordination of human brain tissue and peripheral biological samples under stringent regulatory and ethical standards. They operate within strict institutional review board protocols and maintain chain-of-custody compliance for high-value biospecimens used in psychiatric, neurological, and neurodegenerative disease research. Technical expertise includes cryogenic storage, tissue banking protocols, donor consent management, and secure transport of human tissue under FDA and NIH guidelines. Their key differentiator lies in their state-sanctioned authority to facilitate donor programs and coordinate with medical examiners and academic institutions to source ethically derived specimens for federally funded research. The agency’s primary federal partner is the Department of Health and Human Services, specifically supporting divisions engaged in mental health and neuroscience research, such as the National Institute of Mental Health. Work performed includes end-to-end specimen provisioning, including donor screening, tissue acquisition, and peripheral service support such as data linkage and sample documentation. This reflects a focused, mission-aligned relationship centered on advancing public health research through controlled access to human biospecimens. Their primary industry focus is in NAICS 621991, which encompasses blood and organ banking services extended to neural tissue. This positions them as a niche provider in the human biospecimen supply chain, serving the specialized needs of neuroscientific research rather than general clinical or transplant services. As a state governmental entity headquartered in Richmond, Virginia, the organization operates under public authority with no private certifications. Its structure as a 2A entity indicates it is a state agency with direct governmental oversight. Geographically, its operations are anchored in Virginia but serve national research priorities through federal partnerships.

Key Performance Metrics

Awards Count

135

All time

Active

7

Currently performing

Completed

128

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services$1.7B99.6%
Other agencies (2 agencies, <0.5% each)$7.0M0.4%
Awards by NAICS
Export
- Unknown NAICS$1.7B99.8%
Others - Other NAICS codes (3 codes, <0.5% each)$3.2M0.2%
Awards by Agency Over Time
Awards by Place of Performance

Compete with COMMONWEALTH OF VIRGINIA STATE BOARD OF HEALTH

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for COMMONWEALTH OF VIRGINIA STATE BOARD OF HEALTH

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in COMMONWEALTH OF VIRGINIA STATE BOARD OF HEALTH's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding for U.S. small business concerns (SBCs) to conduct research and development of commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants must be for-profit entities located in the U.S., owned more than 50 percent by U.S. citizens or permanent residents, and employ no more than 500 people. The program accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being NIH-specific options to accelerate development. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on an overall impact score, considering commercial potential, technical feasibility, and the quality of the commercialization plan. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines; notably, several institutes, including NIAID and NIAMS, do not accept clinical trials under this NOFO. Applicants must maintain active registrations in SAM, possess a Unique Entity Identifier, and comply with cybersecurity incident reporting requirements, including notifying HHS within 48 hours of a discovery.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the project toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being specific to the NIH. Budget limits vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the environment for success. While clinical trials are generally optional, they are prohibited for specific components, including all FDA centers and several NIH institutes such as NIAMS and NIDCR. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. All applications must be submitted electronically, with a final expiration date of April 06, 2027.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage research and development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including technical assistance for regulatory and intellectual property strategies, manufacturing scale-up, independent replication of key studies, and clinical trials. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible applicants must be for-profit organizations with no more than 500 employees and maintain active registrations in the System for Award Management and the SBA Company Registry. Project periods are limited to a maximum of three years, with budget ceilings varying by participating Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via NIH peer review based on scientific and technical merit, commercial potential, and relevance to program priorities. Key submission requirements include a detailed regulatory plan and a CRP progress report, while costs for patent or FDA filing fees and separate Technical and Business Assistance funding are strictly prohibited.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details